Kasey J Leger1,2, K Scott Baker1,2,3, Kara L Cushing-Haugen4, Mary E D Flowers3,5, Wendy M Leisenring3,4, Paul J Martin3,5, Jason A Mendoza1,2, Kerryn W Reding4,6, Karen L Syrjala3,7, Stephanie J Lee3,5, Eric J Chow1,2,3,4. 1. Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington. 2. Seattle Children's Hospital, Seattle, Washington. 3. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 4. Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 5. Department of Medicine, University of Washington School of Medicine, Seattle, Washington. 6. University of Washington School of Nursing, Seattle, Washington. 7. Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington.
Abstract
BACKGROUND: The objective of this study was to evaluate whether modifiable cardiovascular risk conditions and lifestyle factors were temporally associated with an increased risk for ischemic heart disease and overall mortality in a cohort of hematopoietic cell transplantation (HCT) survivors. METHODS: HCT recipients who had survived for ≥1 year, were ≥20 years old, and had undergone transplantation between 1970 and 2010 at a transplant referral center were surveyed in 2010-2011 about cardiovascular health and lifestyle factors (n = 3833). Respondents (n = 2360 [61.6%]) were followed to 2016 for incident ischemic heart disease and overall mortality. RESULTS: Among the 2360 transplant survivors (median age at the baseline survey, 55.9 years; median time since transplantation, 10.8 years), 162 (6.9%) reported ischemic heart disease at the baseline survey. Among those without ischemic heart disease at the baseline survey (n = 2198), the 5-year cumulative incidence of subsequent ischemic heart disease was 4.3%. Obesity, dyslipidemia, diabetes, and physical inactivity at baseline were associated with an increased risk for subsequent ischemic heart disease (hazard ratio [HRs] ≥ 1.8). Greater physical activity and fruit/vegetable intake at baseline were associated with subsequent lower overall mortality (HRs ≤ 0.7). When jointly considered, each additional cardiovascular risk condition and each adverse lifestyle factor were independently associated with subsequent ischemic heart disease (HR for risk conditions, 1.4; 95% confidence interval [CI], 1.0-1.9; HR for lifestyle factors, 1.9; 95% CI, 1.2-2.9), and adverse lifestyle factors remained associated with overall mortality (HR, 1.8; 95% CI, 1.5-2.3). CONCLUSIONS: These results support strong efforts to promote healthy lifestyle behaviors and to treat cardiovascular risk factors aggressively in HCT survivors. This may reduce future ischemic heart disease and overall mortality in this high-risk population. Cancer 2018;124:1507-15.
BACKGROUND: The objective of this study was to evaluate whether modifiable cardiovascular risk conditions and lifestyle factors were temporally associated with an increased risk for ischemic heart disease and overall mortality in a cohort of hematopoietic cell transplantation (HCT) survivors. METHODS: HCT recipients who had survived for ≥1 year, were ≥20 years old, and had undergone transplantation between 1970 and 2010 at a transplant referral center were surveyed in 2010-2011 about cardiovascular health and lifestyle factors (n = 3833). Respondents (n = 2360 [61.6%]) were followed to 2016 for incident ischemic heart disease and overall mortality. RESULTS: Among the 2360 transplant survivors (median age at the baseline survey, 55.9 years; median time since transplantation, 10.8 years), 162 (6.9%) reported ischemic heart disease at the baseline survey. Among those without ischemic heart disease at the baseline survey (n = 2198), the 5-year cumulative incidence of subsequent ischemic heart disease was 4.3%. Obesity, dyslipidemia, diabetes, and physical inactivity at baseline were associated with an increased risk for subsequent ischemic heart disease (hazard ratio [HRs] ≥ 1.8). Greater physical activity and fruit/vegetable intake at baseline were associated with subsequent lower overall mortality (HRs ≤ 0.7). When jointly considered, each additional cardiovascular risk condition and each adverse lifestyle factor were independently associated with subsequent ischemic heart disease (HR for risk conditions, 1.4; 95% confidence interval [CI], 1.0-1.9; HR for lifestyle factors, 1.9; 95% CI, 1.2-2.9), and adverse lifestyle factors remained associated with overall mortality (HR, 1.8; 95% CI, 1.5-2.3). CONCLUSIONS: These results support strong efforts to promote healthy lifestyle behaviors and to treat cardiovascular risk factors aggressively in HCT survivors. This may reduce future ischemic heart disease and overall mortality in this high-risk population. Cancer 2018;124:1507-15.
Authors: Joachim Wiskemann; Peter Dreger; Rainer Schwerdtfeger; Andrea Bondong; Gerhard Huber; Nikolaus Kleindienst; Cornelia M Ulrich; Martin Bohus Journal: Blood Date: 2010-12-29 Impact factor: 22.113
Authors: Eric J Chow; Beth A Mueller; K Scott Baker; Kara L Cushing-Haugen; Mary E D Flowers; Paul J Martin; Debra L Friedman; Stephanie J Lee Journal: Ann Intern Med Date: 2011-07-05 Impact factor: 25.391
Authors: Smita Bhatia; Leslie L Robison; Liton Francisco; Andrea Carter; Yan Liu; Marcia Grant; K Scott Baker; Henry Fung; James G Gurney; Philip B McGlave; Auayporn Nademanee; Norma K C Ramsay; Anthony Stein; Daniel J Weisdorf; Stephen J Forman Journal: Blood Date: 2005-02-08 Impact factor: 22.113
Authors: Eric J Chow; K Scott Baker; Stephanie J Lee; Mary E D Flowers; Kara L Cushing-Haugen; Yoshihiro Inamoto; Nandita Khera; Wendy M Leisenring; Karen L Syrjala; Paul J Martin Journal: J Clin Oncol Date: 2013-12-02 Impact factor: 44.544
Authors: Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel Journal: Circulation Date: 2008-01-22 Impact factor: 29.690
Authors: Eric J Chow; Lynnette Anderson; K Scott Baker; Smita Bhatia; Gregory M T Guilcher; Jennifer T Huang; Wendy Pelletier; Joanna L Perkins; Linda S Rivard; Tal Schechter; Ami J Shah; Karla D Wilson; Kenneth Wong; Satkiran S Grewal; Saro H Armenian; Lillian R Meacham; Daniel A Mulrooney; Sharon M Castellino Journal: Biol Blood Marrow Transplant Date: 2016-01-21 Impact factor: 5.742
Authors: Paul J Martin; George W Counts; Frederick R Appelbaum; Stephanie J Lee; Jean E Sanders; H Joachim Deeg; Mary E D Flowers; Karen L Syrjala; John A Hansen; Rainer F Storb; Barry E Storer Journal: J Clin Oncol Date: 2010-01-11 Impact factor: 44.544
Authors: Heidi Michels Blanck; Cathleen Gillespie; Joel E Kimmons; Jennifer D Seymour; Mary K Serdula Journal: Prev Chronic Dis Date: 2008-03-15 Impact factor: 2.830
Authors: Guilherme H Oliveira; Sadeer G Al-Kindi; Avirup Guha; Amit K Dey; Isaac B Rhea; Marcos J deLima Journal: Bone Marrow Transplant Date: 2020-10-31 Impact factor: 5.483
Authors: Nicholas S Wilcox; Seth J Rotz; McKay Mullen; Evelyn J Song; Betty Ky Hamilton; Javid Moslehi; Saro H Armenian; Joseph C Wu; June-Wha Rhee; Bonnie Ky Journal: Circ Res Date: 2022-02-17 Impact factor: 17.367
Authors: Eric J Chow; Yan Chen; Gregory T Armstrong; Laura-Mae Baldwin; Casey R Cai; Todd M Gibson; Melissa M Hudson; Aaron McDonald; Paul C Nathan; Jeffrey E Olgin; Karen L Syrjala; Emily S Tonorezos; Kevin C Oeffinger; Yutaka Yasui Journal: J Am Heart Assoc Date: 2022-06-08 Impact factor: 6.106
Authors: Saro H Armenian; Dongyun Yang; Jennifer Berano Teh; Liezl C Atencio; Alicia Gonzales; F Lennie Wong; Wendy M Leisenring; Stephen J Forman; Ryotaro Nakamura; Eric J Chow Journal: Blood Adv Date: 2018-07-24
Authors: G Curigliano; D Lenihan; M Fradley; S Ganatra; A Barac; A Blaes; J Herrmann; C Porter; A R Lyon; P Lancellotti; A Patel; J DeCara; J Mitchell; E Harrison; J Moslehi; R Witteles; M G Calabro; R Orecchia; E de Azambuja; J L Zamorano; R Krone; Z Iakobishvili; J Carver; S Armenian; B Ky; D Cardinale; C M Cipolla; S Dent; K Jordan Journal: Ann Oncol Date: 2020-02 Impact factor: 32.976
Authors: Eric J Chow; David R Doody; Chongzhi Di; Saro H Armenian; K Scott Baker; Jonathan B Bricker; Ajay K Gopal; Anna M Hagen; Tyler G Ketterl; Stephanie J Lee; Kerryn W Reding; Jeannette M Schenk; Karen L Syrjala; Sarah A Taylor; Guangxing Wang; Marian L Neuhouser; Jason A Mendoza Journal: J Cancer Surviv Date: 2020-10-10 Impact factor: 4.062